Technical Articles

CD30
重组人anti-cd30 & cd16a reference antibody蛋白是什么？anti-cd30 & cd16a reference antibody靶点蛋白怎么选？｜Anti-CD30 & CD16a Reference Antibody (AFM13)
What Is the Anti-CD30 & CD16a Reference Antibody: The AFM13 Bridging Principle
发布时间 2026-11-04
AFM13 bridges CD30-positive lymphoma cells to NK-cell CD16a. This article explains the tetravalent bispecific architecture and NK-cell engagement readouts.
View details
  • Cancer
  • AFM13
  • CD30
  • CD16a
  • bispecific antibody
  • NK cell
  • lymphoma
  • UA010912
淋巴瘤治疗新曙光：CD30靶向疗法的崛起
New dawn for lymphoma treatment: the rise of CD30 targeted therapy
发布时间 2025-05-14
In the big family of cancer, lymphoma is a complex and huge existence. It originates from the lymphatic hematopoietic system and covers more than 70 different subtypes, collectively referred to as the "lymphoma family".
View details
  • Cancer
  • Lymphoma
  • CD30
Total 2
  • 1
Go to
UA
Link：
Products
Application
Cell FactorTarget Proteins
Custom Services
Custom Protein Expression ServicesCustom SPR Services
About Us
PromotionTechnical ArticlesProduct ApplicationFAQsCitationsCalculator ToolsAbout Us
We Media：
Facebook Linkedin YouTube X Thraeds Pinterest
©2021-2026 all rights reserved UNIV Biotechnology Co.,Ltd.
Privacy Policy
网站备案号 苏ICP备2025207586号-2 浙公网安备33010202004867号
 Business license (three certificates in one)
Tel：+86-25-56221161
E-mail：order@ua-bio.com
All products sold on this website shall not be used for clinical diagnosis or treatment of humans or animals, and shall only be used for non-medical purposes such as industrial or scientific research.